The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
occurrence of venous and/or arterial thrombosis and pregnancy morbidity in the presence of …

Data from basic science experiments is overwhelmingly supportive of the causal role of
immune‐inflammatory response (s) at the core of atherosclerosis, and therefore, the …

Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

Background: Recent failures of drugs that raised high-density lipoprotein (HDL) cholesterol
levels to reduce cardiovascular events in clinical trials have led to increased interest in …

Aim Evidence of a possible connection between gut microbiota and several physiological
processes linked to type 2 diabetes is increasing. However, the effect of multi-strain …

For long time, the role of LDL and inflammation in the pathogenesis of atherosclerosis have
been studied independently from each other and only more recently a common platform has …

Coronary artery disease, in the development of which inflammation mediated by innate
immune cells plays a critical role, is one of the leading causes of death worldwide. The 3 …

Background It is uncertain whether pharmacological reductions in very‐low‐density
lipoproteins (VLDLs), and their component triglyceride and cholesterol could reduce …

The impact of the recommended first-line treatment with metformin on C-reactive protein
(CRP) levels in patients with polycystic ovary syndrome (PCOS) is still controversial. We …

Introduction: Low-density lipoprotein cholesterol (LDL-C) remains a well-established risk
factor for cardiovascular disease (CVD). LDL-C levels are considered primary targets of …